Fresh2 Group (Fresh2 Group) Equity-to-Asset : 0.52 (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Fresh2 Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Fresh2 Group's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $12.92 Mil. Fresh2 Group's Total Assets for the quarter that ended in Jun. 2023 was $24.89 Mil.

The historical rank and industry rank for Fresh2 Group's Equity-to-Asset or its related term are showing as below:

FRES' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.56 Med: 0.06 Max: 0.52
Current: 0.52

During the past 6 years, the highest Equity to Asset Ratio of Fresh2 Group was 0.52. The lowest was -0.56. And the median was 0.06.

FRES's Equity-to-Asset is ranked worse than
62.96% of 1566 companies
in the Biotechnology industry
Industry Median: 0.66 vs FRES: 0.52

Fresh2 Group Equity-to-Asset Historical Data

The historical data trend for Fresh2 Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresh2 Group Equity-to-Asset Chart

Fresh2 Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Equity-to-Asset

Get a 7-Day Free Trial

-0.42

-0.30

0.06

-0.07

-0.34

Fresh2 Group Quarterly Data
	Dec17	Sep18	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Equity-to-Asset	Get a 7-Day Free Trial														0.12	0.17	-0.05	-0.34	0.52

Competitive Comparison of Fresh2 Group's Equity-to-Asset

For the Biotechnology subindustry, Fresh2 Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresh2 Group's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fresh2 Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Fresh2 Group's Equity-to-Asset falls into.

Fresh2 Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Fresh2 Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	-1.962	/	5.805
	=	-0.34

Fresh2 Group's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	12.92	/	24.885
	=

Fresh2 Group (NAS:FRES) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Fresh2 Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Fresh2 Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresh2 Group (Fresh2 Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fresh2 Group Ltd (NAS:FRES) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

0UC0:Germany

Address

650 5TH Avenue, Street 2416, NEW YORK, NY, USA, 10019-6108

Website

https://www.fresh2.co

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.